Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Digoxin: Na+/K+ ATPase Research Workflows
2026-09-11
Digoxin is a versatile Na+/K+ ATPase pump inhibitor for linking ion transport, cardiac contractility modulation, hypoxia signaling, and cell-type-specific antiviral assays. This workflow-centered guide covers dose selection, controls, endpoint design, and troubleshooting for cardiovascular, thyroid eye disease, and chikungunya research.
-
Dehydroepiandrosterone (DHEA) Workflows
2026-09-10
Build reproducible DHEA workflows for granulosa-cell inflammation, PCOS modeling, and neuronal stress assays. This guide distinguishes DHEA as a disease-model perturbation in ovarian studies from its neuroprotective and apoptosis-inhibition use in cell-based experiments.
-
Praeruptorin A Blocks NF-κB in Poly(I:C) Macrophages
2026-09-10
The reference study shows that praeruptorin A suppresses poly(I:C)-induced inflammatory activation in RAW264.7 macrophages, combining RNA sequencing with targeted molecular validation. Its main contribution is to connect transcriptomic enrichment of inflammatory pathways with reduced NF-κB activity and lower expression of selected inflammatory genes, while also defining a concentration range relevant to experimental replication.
-
Forsythoside E: PKM2 Inhibitor Workflow
2026-09-09
Forsythoside E supports a mechanism-led workflow for connecting PKM2 tetramerization with macrophage metabolism, STAT3 signaling, and inflammatory phenotypes. Its strongest use case is an integrated in vitro-to-in vivo strategy for macrophage M2 polarization and sepsis-induced liver injury research, with practical controls for solubility, serum binding, and pathway validation.
-
MK-1775: Reading Wee1 Checkpoint Biology
2026-09-09
Explore how MK-1775, a selective Wee1 kinase inhibitor, changes the interpretation of cancer drug-response assays. This guide connects checkpoint biology with the crucial distinction between growth inhibition and true cell killing.
-
Trametinib and the Next Layer of MAPK Translation
2026-09-08
Trametinib (GSK1120212) offers a precise way to connect MEK-ERK pathway suppression with cell-state outcomes while opening a disciplined research question around APEX2-dependent TERT expression. This thought-leadership framework combines mechanistic biology, assay design, translational interpretation, and practical guidance for oncology researchers.
-
Biotin-HPDP for Reversible Thiol Labeling
2026-09-08
Biotin-HPDP combines selective cysteine-thiol chemistry with a cleavable disulfide linkage, supporting S-nitrosylation studies, affinity enrichment, and redox-sensitive protein workflows. Its reversible design is especially useful when biochemical capture must be paired with functional studies such as TRPV1 palmitoylation and pain signaling.
-
FPS-ZM1: RAGE Inhibitor Assay Guide
2026-09-07
A scenario-based guide to using FPS-ZM1 (SKU C3723) to investigate RAGE-dependent effects in viability, cytotoxicity, metabolic-stress, and neuroinflammation experiments. It connects solvent control, assay design, interpretation, and vendor selection with current RAGE/POMC and amyloid beta evidence.
-
APS–miR-183-5p Activates Keap1-Nrf2 in Fish Cells
2026-09-07
The reference study identifies miR-183-5p as a mechanistic link between Astragalus polysaccharides and Keap1-Nrf2 antioxidant signaling in large yellow croaker head kidney cells. Its findings connect improved redox control with reduced mitochondrial injury, apoptosis, and pyroptosis, while also clarifying how cell-based oxidative-stress models can inform aquaculture and programmed cell death research.
-
Nocodazole Workflows for Microtubule Dynamics
2026-09-05
Nocodazole converts microtubule disruption into a controllable experimental variable for cell-cycle, trafficking, and infection-entry studies. This guide translates evidence from Drosophila S2 cell infection research into practical dosing, washout, imaging, and troubleshooting strategies.
-
Neuromedin S (rat): Practical GPCR Workflow
2026-09-04
Neuromedin S (rat) provides a chemically defined endogenous peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein signaling assays. It is intended for research workflows, with defined handling and storage requirements, and should not be used for diagnostic, medical, or therapeutic purposes.
-
Polygodial: TRPA1 Channel Activator Research Guide
2026-09-04
Polygodial is a DMSO-soluble TRPA1 channel activator for controlled ion-channel, sensory-neuron, and epithelial signaling studies. The reference study links TRPA1 activation with calcium influx, NFAT activity, and TSLP production, but it does not establish polygodial-specific activity in nasal epithelial cells.
-
Allosteric PDK4 Inhibitors: Study Insights
2026-09-03
Lee and colleagues developed an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent biochemical inhibitor with favorable early drug-discovery properties. The study connected PDK4 inhibition with improved glucose tolerance, reduced allergic responses, and anticancer phenotypes, while also showing why enzyme potency, pharmacokinetics, and disease-model outcomes must be interpreted separately.
-
Phenothiazines, ROS, and Autophagy in Antibacterial Macropha
2026-09-03
Qiu et al. show that phenothiazines can strengthen macrophage control of intracellular bacteria by increasing lysosomal activity, reactive oxygen species, and autophagy. Inhibitor and scavenger experiments support a host-directed mechanism, while the perphenazine infection model provides in vivo evidence that this strategy can reduce Salmonella-associated tissue damage and inflammation.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-09-02
Build sensitive, flexible rabbit-primary detection into immunofluorescence, ICC, IHC, and flow cytometry workflows with a Cy3-conjugated secondary antibody. This practical guide translates a hyperoxia–ATII cell study into assay design, multiplex imaging, quantitative analysis, and troubleshooting decisions.